# Transdermal administration of herbal essential oil alleviates high-fat diet-induced obesity by regulating metabolism and gut microbiota

**Authors:** Zu-Wen Ye, Qi-Yue Yang, Dong-Hua Yang, Qiao-Hong Lin, Xiao-Xia Liu, Feng-Qin Li, Fang-Fang Yan, Ping Luo, Si Qin, Fang Wang

PMC · DOI: 10.3389/fphar.2025.1565030 · Frontiers in Pharmacology · 2025-03-19

## TL;DR

A herbal essential oil applied through the skin helps reduce obesity by improving metabolism and gut bacteria in rats fed a high-fat diet.

## Contribution

The study demonstrates the anti-obesity effects of transdermal ZhiZhu essential oil through metabolic and microbiota modulation in a high-fat diet model.

## Key findings

- ZBEO reduced lipid accumulation in HepG2 cells and led to weight loss in obese rats.
- Transdermal ZBEO improved serum metabolic indexes linked to the POMC/CART signaling pathway.
- ZBEO altered gut microbiota, increasing beneficial bacteria and affecting obesity-related metabolic pathways.

## Abstract

Obesity, a global health challenge, is characterized by excessive fat accumulation and associated metabolic disorders. The ZhiZhu decoction, a traditional Chinese herbal formula consisting of Citrus aurantium L. (ZS, ZhiShi in Chinese) and Atractylodes macrocephala Koidz (BZ, Baizhu in Chinese), is widely recognized in clinics for its gastrointestinal regulatory effects.

The chemical composition of ZS-BZ essential oil (ZBEO) was characterized using gas chromatography-mass spectrometry (GC-MS). Concurrently, we conducted in vitro investigations using HepG2 hepatoma cells to evaluate its anti-lipid deposition potential. To further elucidate the anti-obesity mechanisms, an in vivo model was established through high-fat diet (HFD)-induced obese rats, followed by transdermal ZBEO administration. Systemic analyses were performed integrating serum metabolomic profiling via UPLC-QTOF-MS and gut microbiota dynamics assessment through 16S rRNA gene sequencing.

ZBEO, rich in atractylon, D-limonene, and γ-elemene and shown to reduce lipid accumulation. Transdermal ZBEO administration in obese rats led to significant weight loss and improved serum metabolic indexes related to the POMC/CART signaling pathway. Additionally, ZBEO altered gut microbiota, enhancing beneficial bacteria and affecting metabolic pathways linked to obesity.

We discovered that ZBEO exerts a significant influence on obesity by modulating key biological processes, including glucose metabolism, lipid metabolism, and the composition of gut microbiota.

## Linked entities

- **Chemicals:** atractylon (PubChem CID 3080635), D-limonene (PubChem CID 440917)
- **Diseases:** obesity (MONDO:0011122)

## Full-text entities

- **Genes:** Pomc (proopiomelanocortin) [NCBI Gene 24664] {aka ACTH, Pomc1, Pomc2, alphaMSH}, Cartpt (CART prepropeptide) [NCBI Gene 29131] {aka Cart}
- **Diseases:** Obesity (MESH:D009765), hepatoma (MESH:D006528), metabolic disorders (MESH:D008659), weight loss (MESH:D015431)
- **Species:** Atractylodes macrocephala (species) [taxon 265785], Rattus norvegicus (brown rat, species) [taxon 10116]
- **Cell lines:** HepG2 — Homo sapiens (Human), Hepatoblastoma, Cancer cell line (CVCL_0027)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC11962428/full.md

## Figures

8 figures with captions in the complete paper: https://tomesphere.com/paper/PMC11962428/full.md

## References

54 references — full list in the complete paper: https://tomesphere.com/paper/PMC11962428/full.md

---
Source: https://tomesphere.com/paper/PMC11962428